Amarantus BioScience Holdings, Inc. Share Price
Equities
AMBS
US02300U2050
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | 0.00% | 0.00% | -80.00% |
Sales 2014 | - | Sales 2015 | - | Capitalization | 85.72L 72Cr |
---|---|---|---|---|---|
Net income 2014 | -2.7Cr -225.45Cr | Net income 2015 | -2.5Cr -208.75Cr | EV / Sales 2014 | - |
Net cash position 2014 | 89T 74.32L | Net Debt 2015 | 29.65L 25Cr | EV / Sales 2015 | - |
P/E ratio 2014 |
-2.06
x | P/E ratio 2015 |
-0.15
x | Employees | 12 |
Yield 2014 * |
-
| Yield 2015 |
-
| Free-Float | 100% |
3 months | -66.67% | ||
6 months | -80.00% | ||
Current year | -80.00% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 79 | 14/08/14 | |
Founder | 41 | 14/08/14 | |
Donald Huffman
CEO | Chief Executive Officer | 77 | 22/14/22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Donald Huffman
CEO | Chief Executive Officer | 77 | 22/14/22 |
Founder | 79 | 14/08/14 | |
Founder | 41 | 14/08/14 |
Date | Price | Change | Volume |
---|---|---|---|
15/24/15 | 0.0001 | 0.00% | 300,401 |
08/24/08 | 0.0001 | 0.00% | 200 |
Delayed Quote OTC Markets, May 16, 2024 at 01:21 am IST
More quotes1st Jan change | Capi. | |
---|---|---|
-80.00% | 63.04T | |
+29.77% | 4.95TCr | |
+1.00% | 4.26TCr | |
+50.47% | 4.25TCr | |
-5.26% | 2.91TCr | |
+13.68% | 2.66TCr | |
-22.99% | 1.86TCr | |
+8.22% | 1.32TCr | |
+32.41% | 1.25TCr | |
-1.62% | 1.2TCr |
- Stock Market
- Equities
- AMBS Stock